Coherus BioSciences

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CHRS and other ETFs, options, and stocks.

About CHRS

Coherus BioSciences, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of biosimilar therapeutics. Its products include UDENYCA and LOQTORZI.

CEO

Denny M. Lanfear

CEODenny M. Lanfear

Employees

228

Employees228

Headquarters

Redwood City, California

HeadquartersRedwood City, California

Founded

2010

Founded2010

Employees

228

Employees228

CHRS Key Statistics

Market cap

118.21M

Market cap118.21M

Price-Earnings ratio

4.07

Price-Earnings ratio4.07

Dividend yield

—

Dividend yield—

Average volume

2.06M

Average volume2.06M

High today

$1.05

High today$1.05

Low today

$0.99

Low today$0.99

Open price

$1.00

Open price$1.00

Volume

1.07M

Volume1.07M

52 Week high

$2.43

52 Week high$2.43

52 Week low

$0.6603

52 Week low$0.6603

CHRS News

TipRanks 5h

Coherus Biosciences Board Member Stolper Steps Down

Coherus Biosciences ( (CHRS) ) has issued an update. On April 22, 2025, Mark D. Stolper, a member of the Board of Directors at Coherus BioSciences, announced h...

Analyst ratings

67%

of 6 ratings

Buy

66.7%

Hold

33.3%

Sell